Anthracycline-induced Cardiotoxicity

Explore clinical trials studying Anthracycline-induced Cardiotoxicity. Study availability and eligibility vary by location and protocol.

5 public trials 1 recruiting study

Refine in advanced search Browse all conditions

Anthracycline-induced Cardiotoxicity trial results

Recruiting

NCT07528586

Conditions: Anthracycline-induced Cardiotoxicity, Cardiotoxicity, Cardiovascular Diseases, +7 more
Locations: Robert Bosch Gesellschaft für Medizinische Forschung mbH Stuttgart, Germany

Not Yet Recruiting

NCT07572175

Conditions: Anthracycline-induced Cardiotoxicity, Cardiotoxicity, Cardiovascular Diseases, +18 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

Not Yet Recruiting

NCT07254221

Conditions: Anthracycline Related Cardiotoxicity in Breast Cancer, Anthracycline-induced Cardiac Toxicity, Anthracycline-induced Cardiotoxicity, +16 more
Locations: Motahari Breast Cancer Clinic Shiraz, Fars, Iran

Kowsar Hospital, Fars Heart Foundation Shiraz, Fars, Iran

Toba Oncology Department, Mazandaran University of Medical Sciences Sari, Mazandaran, Iran

Modarres Hospital, Shahid Beheshti University of Medical Sciences Tehran, Tehran Province, Iran

Completed

NCT01805778

Conditions: Anthracycline-induced Cardiotoxicity
Locations: Children's Hospital of Orange County Orange, California, United States

McMaster Children's Hospital Hamilton, Ontario, Canada

London Health Sciences Centre London, Ontario, Canada

Children's Hospital of Eastern Ontario Ottawa, Ontario, Canada

Active, Not Recruiting

NCT07442578

Conditions: Anthracycline-induced Cardiotoxicity, Cardiotoxicity, Cardiovascular Diseases, +8 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States